Staff20192020202120222023
Personnel at the end of the year426615732647564
Staff turnover in EUR168,440532,843245,371430,088422,479
Turnover LabelEUREUREUREUREUR
The share: stated in EUR20192020202120222023
Shares outstanding (in mn.)31.9632.8934.2337.6637.66
Dividend per share-----
Basic earnings per share-3.263.01-15.40-4.42-5.53
P/L in EUR million under IAS/IFRS20192020202120222023
Turnover71.8327.7179.6278.3238.3
Operating income (EBIT)-105.050.3-525.7134.0-107.5
Earnings before taxes-106.522.5-591.021.8-182.7
Annual net profit/ loss-103.097.9-514.5-151.1-189.7
Balance sheet in EUR million under IAS/IFRS20192020202120222023
Assets
Total current assets303.71,206.81,133.01,089.0814.0
Total fixed assets192.7452.71,423.31,307.91,212.3
Total assets496.41,659.52,556.32,396.92,026.3
Liabilities
Total short-term liabilities61.6200.5284.5278.3264.3
Total long-term liabilities40.2837.72,026.81,961.21,713.0
Total provisions0.01.51.68.728.4
Equity capital394.7621.3244.9157.449.0
Total liabilities496.41,659.52,556.32,396.92,026.3
Management:
Jean-Paul Kress
Barbara Krebs-Pohl
Lucinda Crabtree
Tim Demuth
Charlotte Lohmann
Board:
Marc Cluzel
Andrew Cheng
George Golumbeski
Krisja Vermeylen
Michael Brosnan
Sharon Curran
Shareholding in %:
Adage Capital Management LP 5.02
Armistice Capital LLC 4.69
Caligan Partners LP 2.81
DWS Investment GmbH 2.62
Goldman Sachs & Co. LLC (Private Banking) 10.99
Kynam Capital Management LP 10.62
Norges Bank Investment Management 4.18
Novartis AG 11.57
RP Management LLC (Investment Management) 3.55
The Vanguard Group, Inc. 3.57
Freefloat 40.38
Address: Semmelweisstrasse 7, 82152 Planegg
T: +49-89-89927-0
F: +49-89-89927-222
I: http://www.morphosys.de
E: info@morphosys.com